Sars-cov-2 mrna-1273 (6m-5y) vaccine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with sars-cov-2 mrna-1273 (6m-5y) vaccine
S
- Sandimmune (cyclosporine)
- Saphnelo (anifrolumab)
- Sarclisa (isatuximab)
- sarilumab
- satralizumab
- Scemblix (asciminib)
- Selarsdi (ustekinumab)
- Selestoject (betamethasone)
- selinexor
- Shingrix (zoster vaccine, recombinant)
- Siklos (hydroxyurea)
- Siliq (brodalumab)
- siltuximab
- Simlandi (adalimumab)
- Simponi (golimumab)
- Simponi Aria (golimumab)
- Simulect (basiliximab)
- siponimod
- sirolimus
- sirolimus protein-bound
- sirolimus topical
- Skyrizi (risankizumab)
- Skysona (elivaldogene autotemcel)
- smallpox and monkeypox vaccine
- smallpox vaccine
- Solu-Cortef (hydrocortisone)
- Solu-Medrol (methylprednisolone)
- Solurex (dexamethasone)
- Solurex LA (dexamethasone)
- sotrovimab
- Sotyktu (deucravacitinib)
- spesolimab
- Spevigo (spesolimab)
- Sprycel (dasatinib)
- Stamaril (yellow fever vaccine)
- staphage lysate (spl)
- Stelara (ustekinumab)
- Sterapred (prednisone)
- Sterapred DS (prednisone)
- streptozocin
- Sylvant (siltuximab)
- Symbicort (budesonide / formoterol)
- Synribo (omacetaxine)
More about sars-cov-2 mrna-1273 (6m-5y) vaccine
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.